Experimental drug curbs excessive alcohol use in rats
A new compound synthesized byEli Lilly & Co. showed such promise in animal tests that "it should be developed for clinical use in alcoholism," according to neuroscientist Markus Heilig, clinical director at the National Institute on Alcoholi Abuse & Alcoholism (NIAA). "We're thrilled, because this has been a dream for over a decade for many of us," says Heilig, who led the team that evaluated the compound's effect in rats
More...
